RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,053,341 | -33.3% | 8,329,767 | -0.5% | 0.00% | -33.3% |
| Q2 2023 | $105,098,663 | -19.6% | 8,367,728 | +5.4% | 0.00% | -25.0% |
| Q1 2023 | $130,700,814 | +9.4% | 7,935,690 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $119,489,896 | -21.0% | 7,997,985 | +18.4% | 0.00% | -20.0% |
| Q3 2022 | $151,169,000 | +37.2% | 6,757,637 | +2.7% | 0.01% | +25.0% |
| Q2 2022 | $110,168,000 | -38.4% | 6,577,178 | +10.1% | 0.00% | -20.0% |
| Q1 2022 | $178,807,000 | -2.9% | 5,974,183 | -0.3% | 0.01% | 0.0% |
| Q4 2021 | $184,062,000 | +9.1% | 5,993,613 | +12.0% | 0.01% | 0.0% |
| Q3 2021 | $168,768,000 | +1.6% | 5,352,612 | +17.9% | 0.01% | 0.0% |
| Q2 2021 | $166,131,000 | +26.5% | 4,540,330 | +19.5% | 0.01% | +25.0% |
| Q1 2021 | $131,322,000 | +0.1% | 3,798,730 | +20.3% | 0.00% | 0.0% |
| Q4 2020 | $131,203,000 | +49.2% | 3,156,974 | +52.8% | 0.00% | +33.3% |
| Q3 2020 | $87,967,000 | – | 2,065,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |